Simplex Trading’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Simplex Trading's INMB Position: Q2 2026 in Review
Simplex Trading reduced its INmune Bio (INMB) stake by 99% in Q2 2026, selling an estimated $4.63K and leaving 23 shares worth $37. The position accounts for ﹤0.01% of the portfolio, ranked #9136.
Simplex Trading first reported a position in INMB in Q2 2021 and has held it in 18 quarters since. The position peaked at $334K in Q1 2025. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.
- Simplex Trading held 23 shares of INmune Bio worth $37 as of Q2 2026.
- Simplex Trading sold 3,343 INmune Bio shares in Q2 2026, an estimated $4.63K.
- INmune Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #9136 holding.
- Simplex Trading first reported a position in INmune Bio in Q2 2021 and has held it in 18 quarters since.
- Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
- 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.